Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 0.95.

  • Mangoceuticals' Equity Ratio rose 511.33% to 0.95 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.95, marking a year-over-year increase of 511.33%. This contributed to the annual value of 0.91 for FY2024, which is 2306.05% up from last year.
  • Mangoceuticals' Equity Ratio amounted to 0.95 in Q3 2025, which was up 511.33% from 0.92 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Equity Ratio peaked at 0.95 during Q3 2025, and registered a low of 3.18 during Q1 2024.
  • Over the past 3 years, Mangoceuticals' median Equity Ratio value was 0.91 (recorded in 2024), while the average stood at 0.48.
  • Per our database at Business Quant, Mangoceuticals' Equity Ratio tumbled by 35.75% in 2024 and then surged by 12927.94% in 2025.
  • Mangoceuticals' Equity Ratio (Quarter) stood at 0.74 in 2023, then grew by 23.06% to 0.91 in 2024, then grew by 4.86% to 0.95 in 2025.
  • Its Equity Ratio stands at 0.95 for Q3 2025, versus 0.92 for Q2 2025 and 0.93 for Q1 2025.